June 2012

Cover Story »

Update on HIV Prevention Techniques

Orlando—The incidence of HIV has been relatively stable in recent years, and therapeutic developments have prolonged life for people with the virus. Still, with 1.2 million people in the United States having HIV and 50,000 new infections occurring each year, healthcare professionals, pharmaceutical companies, and the government are pouring resources into finding ways to improve patients’ health.



Cover Story »

Insurers Expected to Issue >$1 Billion in Rebates

By August 1, employers, employees, and individuals from across the United States will receive refunds from health insurance companies that failed to meet minimum standards set forth in the Patient Protection and Affordable Care Act (ACA).

An ACA provision, lauded by the Obama administration for looking out for consumers’ interests, set required medical loss ratios (MLRs) for insurers. Insurers covering employers or groups with ≥50 people must spend ≥85% of the premiums they collect on medical care, while those covering ≤50 people have a minimum of 80%.



Cover Story »

Patient Satisfaction and Quality and Cost of Care

Quality of healthcare is determined by various metrics, including processes of care and health outcomes. An additional component of quality healthcare is patient experience and satisfaction. The Centers for Medicare & Medicaid Services and the National Committee on Quality Assurance require participating health plans to report data on patient satisfaction along with other measures of quality. In addition, health plans utilize patient satisfaction measures to evaluate physicians and set incentive compensation rates.



News Connection »

Intervention Designed to Increase Adherence and Improve BP

Much of the racial gap in mortality rates between whites and African Americans can be attributed to the disproportionate number of African Americans with poorly controlled hypertension. Lack of adherence to medication regimens may explain the poor blood pressure (BP) control among African Americans. The adverse effect of inadequate adherence on cardiovascular mortality and morbidity has been well established, creating a need for interventions designed to improve adherence and narrow the racial gap in outcomes related to hypertension.



News Connection »

Rates of Reexcision after Breast Cancer Surgery

Efforts at healthcare reform have included a focus on increased physician and hospital accountability and transparency of outcomes. Mortality is a common measurement tool used to assess surgical outcomes, but for procedures associated with low mortality, assessing outcomes as a measure of quality of care has been challenging.



News Connection »

Initial Stent Implantation for Stable Coronary Artery Disease

A new meta-analysis comparing stent implantation and medical therapy versus medical therapy alone for patients with stable coronary artery disease (CAD) found that initial stent implantation did not appear to offer a benefit in terms of preventing death, nonfatal myocardial infarction (MI), unplanned revascularization, or angina when compared with medical therapy alone. These findings were published in Archives of Internal Medicine [2012;172(4):312-319].



Healthcare Reform »

Availability of ICU Beds and Outcomes

The demand for beds in intensive care units (ICUs) may at times exceed supply, necessitating prioritization of admissions. As the population ages, demands for critical care services are expected to increase, raising concerns about plans for allocation of resources such as ICU beds when demand exceeds supply.



News Connection »

Decreasing Inappropriate Urinary Catheter Use in Hospitals

Urinary tract infections represent a large portion of all hospital-acquired infections, with catheter-associated urinary tract infection (CAUTI) accounting for the majority of cases. Results of a retrospective analysis from 163 inpatient units in 71 participating Michigan hospitals found that reducing inappropriate urinary catheter use was associated with a considerable reduction in catheter use and improved compliance with appropriate use. The effect of the statewide intervention was sustained for almost 2 years [Arch Intern Med. 2012;172(3):255-260].



News Connection »

Ulipristal Acetate and Uterine Fibroids and Fibroid-Related Bleeding

Results of a randomized, double-blind, placebo-controlled, phase 3 study [N Engl J Med. 2012;366(5):409-420] show that oral ulipristal acetate at a dose of 5 or 10 mg/day given for 13 weeks is effective in controlling excessive bleeding and shrinking fibroids in women with symptomatic fibroids.



News Connection »

PSA Screening Reduces Prostate Cancer Mortality

A new report with extended follow-up from the European Randomized Study of Screening for Prostate Cancer (ERSPC) strengthened the study’s previous findings by finding once again that prostate-specific antigen (PSA) screening for men significantly reduced mortality from prostate cancer, but did not have an affect on all-cause mortality. These latest findings, which include a median of 11 years of follow-up data, were reported in the New England Journal of Medicine [2012;366(11):981-90].



News Connection »

Statins before Surgery Cut Risk of Cardiac Complications

Administering statins before surgery in statin-naive patients lowered the risk of myocardial infarction (MI) and atrial fibrillation. The drugs also reduced the time patients were hospitalized, according to results of a recent meta-analysis [Arch Surg. 2012;147(2):181-189].



News Connection »

Timing of Surgical Intervention for Epilepsy

Worldwide epilepsy accounts for 1% of the burden of disease, a proportion equal to that of lung cancer in men and breast cancer in women. Nearly 80% of the cost of managing and treating epilepsy is associated with the 20% to 40% of patients who have medically intractable disease, according to researchers.



News Connection »

Controlling Diabetes with Bariatric Surgery

Obesity and type 2 diabetes mellitus continue to present one of the most difficult challenges to public health worldwide. Complications associated with diabetes include both macrovascular and microvascular diseases and events such as myocardial infarction, stroke, blindness, neuropathy, and renal failure. Healthcare providers aim to halt progression of diabetes by reducing hyperglycemia, hypertension, dyslipidemia, and other cardiovascular risk factors.



Healthcare Reform »

Reconstructing US Healthcare by Eliminating Waste

In a special communication posted online in the Journal of the American Medical Association, Daniel M. Berwick, MD, MPP, and Andrew D. Hackbarth, MPhil, offered a strategy aimed at Eliminating Waste in US Healthcare [JAMA. 2102;307(14):doi:10.1001/jama.2012.363]. Dr. Berwick is the former president and CEO of the Institute for Healthcare Improvement and the former administrator of the Centers for Medicare & Medicaid Services (CMS). Mr. Hackbarth is affiliated with the Rand Corporation in Santa Monica, California.



Healthcare Reform »

Routine HIV Screening for Medicaid Beneficiaries

A survey of state Medicaid officials and their coverage of HIV screening found that about half of the states surveyed cover routine HIV screening through their Medicaid program while the other half cover only medically necessary testing. The survey was conducted by The Henry J. Kaiser Family Foundation as part of the 2010 update to their Medicaid Benefits Database.



NAMCP Conference »

CMS Demonstration Projects for Dual Eligibles

Orlando—For years, the federal government and states have attempted to rein in costs associated with Medicare and Medicaid. Still, the expenses associated with these programs continue to grow, as the population gets older and more people are unemployed and need assistance to pay for their healthcare.



NAMCP Conference »

Implementation of Accountable Care Organizations

Orlando—Soon after the Department of Health and Human Services (HHS) announced the proposed regulations for accountable care organizations (ACOs) in March 2011, many constituencies in the healthcare industry derided the rules as too cumbersome. They voiced their concerns, and HHS acquiesced to their feedback.



NAMCP Conference »

Medical Homes as Centerpiece of Healthcare Reform

Orlando—In nearly 5 decades as a doctor, Sam JW Romeo has seen numerous industry innovations that did not improve care or cut costs. He is now the medical director at Tower Health & Wellness Center in Turlock, California, which he and other partners opened in 2005.

Of Dr. Romeo’s 6 children, 5 are physicians. The sixth is a licensed clinical social worker. Due to his childrens’ occupations, Dr. Romeo is familiar with all of the recent proposals, particularly those included in the Patient Protection and Affordable Care Act (ACA).



NAMCP Conference »

Options to Prevent Strokes in Patients with Atrial Fibrillation

Orlando—Patients with atrial fibrillation (AF) typically take warfarin to prevent strokes, but pharmaceutical companies are investing significant time and money to find alternative therapies. The FDA approved Pradaxa® (dabigatran etexilate) in October 2010 and Xarelto® (rivaroxaban) in November 2011. In phase 3 trials, both oral drugs were noninferior to warfarin in reducing strokes and systemic embolism, and they were also safer than warfarin.



NAMCP Conference »

Containing Costs Through Healthcare Reform

Orlando—Healthcare spending in the United States has reached $2.25 trillion, accounting for 16% of the country’s gross domestic product (GDP). Most experts expect it to keep rising and predict that by 2025, healthcare spending will account for as much as 20% of the US GDP.



AAN Annual Meeting »

Migraine Guidelines Evaluate Efficacy of Treatments

New Orleans—Despite many treatments available to help prevent migraine in certain people, most migraine sufferers do not use them, according to Stephen D. Silberstein, MD, FACP, FAHS, coauthor of 2 practice guidelines on prevention of episodic migraine [Neurology. 2012;78(17):1337-1353]. The guidelines—one for prescription medications and another for nonsteroidal anti-inflammatory drugs (NSAIDs) and complementary treatments—were codeveloped by the American Academy of Neurology (AAN) and the American Headache Society.



AAN Annual Meeting »

Migraine-Related Direct Medical Costs Lower with OnabotulinumtoxinA

New Orleans—Chronic migraine (CM) patients treated with onabotulinumtoxinA reported a significant decline in emergency department (ED) visits. The results were presented at the AAN meeting during a poster session. The poster was titled Real-World Economic Impact of OnabotulinumtoxinA in Patients with Chronic Migraine.



Biotech Focus »

Adult Vaccination Strategies for Invasive Pneumococcal Disease

Although the 23-valent pneumococcal polysaccharide vaccine (PPSV23) has been recommended for prevention of invasive pneumococcal disease (IPD) in adults since 1983, there have been no conclusive assessments of its ability to prevent nonbacteremic pneumococcal pneumonia (NPP), which causes several hundred thousand illnesses annually in the United States. A newer pediatric conjugate vaccine containing 6 additional serotypes (PCV13) is expected to further reduce pneumococcal disease in children and adults.



Biotech Focus »

Better Prevention of Clostridium Difficile Infections Needed

Most of the substantial increase in Clostridium difficile infections (CDIs) over the past decade in the United States is related to healthcare exposures that may be prevented by reducing unnecessary antibiotic use and interrupting transmission of C. difficile between patients, report investigators in the March 6 Morbidity and Mortality Weekly Report (MMWR) from the Centers for Disease Control and Prevention (CDC) [MMWR Weekly. 2012;61:1-6].



Biotech Focus »

Optimal Response to Natalizumab in MS Patients

Results from a small study found that inhibition of intrathecal antibody synthesis is associated with a complete therapeutic response to natalizumab in patients with aggressive multiple sclerosis (MS). Treatment with natalizumab decreased the rate of disability progression and reduced the number of relapses in the overall study group. Furthermore, nearly half of the patients remained free of new disease activity [Arch Neurol. 2012;69(2):191-197].



Biotech Focus »

Flu Vaccine Less Effective among Elderly

Morbidity from influenza is significant in people ³65 years of age. As a result, annual vaccination is recommended to reduce the burden of influenza in this patient population. New analysis suggests, however, that the influenza vaccination may be associated with reductions in the composite of pneumonia and influenza (P&I) hospitalization and death among the elderly, but not with all-cause mortality alone, according to study results reported online first in the Archives of Internal Medicine [doi:10.001/archintermed.2011.2038].